Stocks · Health care
Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc.
$0.9146-7.6% day◎ Watch
Price
$0.9146
Nov 13, 2026
Day
▼ -7.6%
Market cap
$231.35M
Micro cap (<$300M)
Sector
Health care
Biological Products, (No Diagnostic Substances)
In short
Lineage Cell Therapeutics, Inc. (LCTX) is at $0.9146, down 7.6% on the day. It is a health care company (Biological Products, (No Diagnostic Substances)) listed on NYSE, worth about $231.35M.
Sort Brick verdict: ◎ Watch — the chatter checked against the price and volume.
Live LCTX: insider trades, SEC filings, signal scoreLive data, filters and alerts in the app · Start a 7-day free trial — then $39/mo, cancel anytime
Sources
- Yahoo Finance — price, change, volume · fetched Nov 13, 2026
- SEC EDGAR — company registration, sector, shares outstanding
Every number on this page comes from these public sources, collected and checked by Sort Brick.
Get Sort Brick Daily - free, every evening
One short email every evening: what really moved, what was only noise, and what we logged first, with the times. Free. Information, not investment advice.